Realcan Pharmaceutical Group Co.Ltd(002589) : Realcan Pharmaceutical Group Co.Ltd(002589) asset appraisal report of all equity value projects of shareholders of Tianjin guohuida Health Technology Co., Ltd. involved in the proposed equity acquisition

Realcan Pharmaceutical Group Co.Ltd(002589) : Realcan Pharmaceutical Group Co.Ltd(002589) asset appraisal report on the value of all shareholders’ equity project of Tianjin guohuida Health Technology Co., Ltd. involved in the proposed equity acquisition Realcan Pharmaceutical Group Co.Ltd(002589) : North Northking Information Technology Co.Ltd(002987) ASI Asset Appraisal Office (special general partnership) has accepted the entrustment of your company. According to the relevant national regulations on asset appraisal, based on the principles of independence, objectivity and impartiality, The asset-based method is used to evaluate the value of all shareholders’ equity of Tianjin guohuida Health Technology Co., Ltd. involved in the economic behavior of Realcan Pharmaceutical Group Co.Ltd(002589) proposed equity acquisition. According to the necessary appraisal procedures, the appraisers carried out on-site investigation, market investigation and letter confirmation on the assets and liabilities within the scope of appraisal, and fully reflected the market value of the assets and liabilities entrusted for appraisal on the benchmark date of October 31, 2021. The assets appraisal and appraisal results are reported as follows: I. overview of the client, the appraised unit and the user of the appraisal report. The client of this appraisal is Realcan Pharmaceutical Group Co.Ltd(002589) : the appraised unit is Tianjin guohuida Health Technology Co., Ltd.; the user of the appraisal report is the client The parties related to this economic behavior and other users of the evaluation report permitted by laws and regulations